Biomx Inc
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About PHGE
BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The Company discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).
Find out what a historical investment in Biomx Inc would be worth today using our PHGE stock calculator.
$23.95M
-
0.00%
61.58K
$3.77
$3.32
$3.71
$14.71
$1.50
Ready to start your investing journey with Stake?
Open an accountPHGE FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in PHGE
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PHGE
on Stake
Buy PHGE from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of PHGE from only US$10 with fractional shares
